Lung is an organ where many devastating diseases are commonly diagnosed. Among them, lung cancer is the second-most diagnosed cancer in both men and women, and the most common cause of cancer death. Chronic obstructive pulmonary disease, also known as emphysema and chronic bronchitis, is a very serious disease and the third leading cause of death in the United States. In 2011, it was estimated that 25.9 million Americans had asthma, including 7.1 million children under the age of 18. Asthma is the third leading cause of hospitalization among children under the age of 15 (American Lung Association, http://www.lung.org). In order to study the pathophysiology and/or etiology of these devastating diseases and their underlying mechanisms, the use of accurate models is critical in conjunction with convenient and noninvasive administration of various materials of interest to lung. Mice provide one of the best models to study the molecular mechanisms underlying the pathology and physiology of lung diseases because of the increasing availability of knockout and transgenic mice and a vast amount of available genetic information.
Various methods have been used by a number of investigators in different settings to deliver materials of interest to mouse lungs, including inhalation, intranasal instillation, intratracheal instillation, and intratracheal intubation1-4. The latter procedure has not been routinely used because it is considered rather difficult to perform. Intratracheal intubation described herein is a noninvasive, simple, and quick method to deliver materials of interest to mouse lungs in order to study the effect of the delivered materials on gene expression patterns, pathology and/or physiology of lung5. This technique assures the delivery of exogenous materials to a whole lung and does not involve any survival surgery and thus will likely be approved by any institutional animal care and use committees.